alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Court of Appeals

of the State of Georgia

ATLANTA,____________________

The Court of Appeals hereby passes the following order:

A18A1369. BRENT HANCOCK v. JILL HANCOCK.

Brent Hancock’s motion to withdraw his appeal is hereby GRANTED.

Court of Appeals of the State of Georgia

Clerk’s Office, Atlanta,____________________

I certify that the above is a true extract from

the minutes of the Court of Appeals of Georgia.

Witness my signature and the seal of said court

hereto affixed the day and year last above written.

, Clerk.

March 16, 2018

03/16/2018
# C_2023328EN.01001601.xml

| 18.9.2023 | EN | Official Journal of the European Union | C 328/16 |
| --- | --- | --- | --- |

18.9.2023

EN

Official Journal of the European Union

C 328/16

---

Euro exchange rates (1)

15 September 2023

(2023/C 328/06)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,0658 |
| JPY | Japanese yen | 157,50 |
| DKK | Danish krone | 7,4573 |
| GBP | Pound sterling | 0,85878 |
| SEK | Swedish krona | 11,8730 |
| CHF | Swiss franc | 0,9554 |
| ISK | Iceland króna | 145,30 |
| NOK | Norwegian krone | 11,4220 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,496 |
| HUF | Hungarian forint | 383,75 |
| PLN | Polish zloty | 4,6308 |
| RON | Romanian leu | 4,9698 |
| TRY | Turkish lira | 28,7513 |
| AUD | Australian dollar | 1,6498 |
| CAD | Canadian dollar | 1,4409 |
| HKD | Hong Kong dollar | 8,3416 |
| NZD | New Zealand dollar | 1,8008 |
| SGD | Singapore dollar | 1,4524 |
| KRW | South Korean won | 1 415,78 |
| ZAR | South African rand | 20,2968 |
| CNY | Chinese yuan renminbi | 7,7561 |
| IDR | Indonesian rupiah | 16 379,21 |
| MYR | Malaysian ringgit | 4,9922 |
| PHP | Philippine peso | 60,612 |
| RUB | Russian rouble | |
| THB | Thai baht | 38,145 |
| BRL | Brazilian real | 5,1860 |
| MXN | Mexican peso | 18,2275 |
| INR | Indian rupee | 88,6150 |

Currency

Exchange rate

USD

US dollar

1,0658

JPY

Japanese yen

157,50

DKK

Danish krone

7,4573

GBP

Pound sterling

0,85878

SEK

Swedish krona

11,8730

CHF

Swiss franc

0,9554

ISK

Iceland króna

145,30

NOK

Norwegian krone

11,4220

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,496

HUF

Hungarian forint

383,75

PLN

Polish zloty

4,6308

RON

Romanian leu

4,9698

TRY

Turkish lira

28,7513

AUD

Australian dollar

1,6498

CAD

Canadian dollar

1,4409

HKD

Hong Kong dollar

8,3416

NZD

New Zealand dollar

1,8008

SGD

Singapore dollar

1,4524

KRW

South Korean won

1 415,78

ZAR

South African rand

20,2968

CNY

Chinese yuan renminbi

7,7561

IDR

Indonesian rupiah

16 379,21

MYR

Malaysian ringgit

4,9922

PHP

Philippine peso

60,612

RUB

Russian rouble

THB

Thai baht

38,145

BRL

Brazilian real

5,1860

MXN

Mexican peso

18,2275

INR

Indian rupee

88,6150

---

(1)  
  Source: reference exchange rate published by the ECB.

1

Source

---
#### YOUNG V. THE STATE.

(Decided June 17, 1913.)

Appeal from Houston Circuit Court.

Heard before Hon. H. A. Pearce.

E. H. Hill, for appellant. R. C. Briokell, Attorney General, and W. L. Martin, Assistant Attorney General, for the State.

Th'omas, J. —

Tbe bill of exceptions stricken because not filed within ninety days, and tbe cause affirmed.
Exhibit 32.2

# CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

# SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report of Theragenics Corporation®, (the Company) on Form 10-Q for the
period ending September 30, 2003 as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, James A. MacLennan, Treasurer and Chief Financial
Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:

|(1) |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the
               Securities Exchange Act of 1934; and
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report fairly presents, in all material
               respects, the financial condition and results of operation of the Company.
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------

By:   /s/ James A MacLennan

 James
A. MacLennan         Treasurer and Chief Financial Officer         November 14, 2003
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-END>                               DEC-31-1997
<CASH>                                          66,453
<SECURITIES>                                         0
<RECEIVABLES>                                  479,987
<ALLOWANCES>                                         0
<INVENTORY>                                    135,019
<CURRENT-ASSETS>                               703,072
<PP&E>                                       2,012,825
<DEPRECIATION>                                 431,974
<TOTAL-ASSETS>                               2,467,572
<CURRENT-LIABILITIES>                          409,794
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       297,570
<OTHER-SE>                                     328,863
<TOTAL-LIABILITY-AND-EQUITY>                 2,467,572
<SALES>                                      2,357,476
<TOTAL-REVENUES>                             2,462,096
<CGS>                                          362,822
<TOTAL-COSTS>                                1,816,046
<OTHER-EXPENSES>                               (3,711)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             108,066
<INCOME-PRETAX>                                178,873
<INCOME-TAX>                                    20,132
<INCOME-CONTINUING>                            158,741
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   158,741
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
§ 50.108 Funding related to Covered Federal Reserve Facility Funding. ( a ) *Treatment of Covered Federal Reserve Facility Funding.* Notwithstanding any other section of this part and except as provided in paragraph (b) of this section, available stable funding amounts and required stable funding amounts related to Covered Federal Reserve Facility Funding and the assets securing Covered Federal Reserve Facility Funding are excluded from the calculation of a national bank's or Federal savings association's net stable funding ratio calculated under § 50.100(b).
( b ) *Exception.* To the extent the Covered Federal Reserve Facility Funding is secured by securities, debt obligations, or other instruments issued by the national bank or Federal savings association or one of its consolidated subsidiaries, the Covered Federal Reserve Facility Funding and assets securing the Covered Federal Reserve Facility Funding are not subject to paragraph (a) of this section and the available stable funding amount and required stable funding amount must be included in the national bank's or Federal savings association's net stable funding ratio calculated under § 50.100(b).
§ 390.316 With recourse. ( a ) The term *with recourse* means, in connection with the sale of a loan or a participation interest in a loan, an agreement or arrangement under which the purchaser is to be entitled to receive from the seller a sum of money or thing of value, whether tangible or intangible (including any substitution), upon default in payment of any loan involved or any part thereof or to withhold or to have withheld from the seller a sum of money or anything of value by way of security against default. The recourse liability resulting from a sale with recourse shall be the total book value of any loan sold with recourse less: ( 1 ) The amount of any insurance or guarantee against loss in the event of default provided by a third party,
( 2 ) The amount of any loss to be borne by the purchaser in the event of default, and
( 3 ) The amount of any loss resulting from a recourse obligation entered on the books and records of the State savings association.
( b ) The term *with recourse* does not include loans or interests therein where the agreement of sale provides for the State savings association directly or indirectly ( 1 ) To hold or retain a subordinate interest in a specified percentage of the loans or interests; or
( 2 ) To guarantee against loss up to a specified percentage of the loans or interests, which specified percentage shall not exceed ten percent of the outstanding balance of the loans or interests at the time of sale: *Provided,* that the State savings association designates adequate reserves for the subordinate interest or guarantee.
( c ) This definition does not apply for purposes of determining the capital adequacy requirements under part 324 of this chapter.
[76 FR 47655, Aug. 5, 2011, as amended at 83 FR 17743, Apr. 24, 2018]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM HELMSTAR
GROUP, INC. AND SUBSIDIARIES'  CONDENSED  CONSOLIDATED BALANCE SHEET (UNAUDITED)
AND CONDENSED  CONSOLIDATED  STATEMENT OF OPERATIONS (UNAUDITED) FOR THE INTERIM
PERIOD ENDED SEPTEMBER 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                         690,369
<SECURITIES>                                67,337,583
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         509,899
<DEPRECIATION>                                 284,311
<TOTAL-ASSETS>                              80,999,227
<CURRENT-LIABILITIES>                                0
<BONDS>                                     72,750,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       674,960
<OTHER-SE>                                   5,772,618
<TOTAL-LIABILITY-AND-EQUITY>                80,999,227
<SALES>                                              0
<TOTAL-REVENUES>                             4,713,415
<CGS>                                                0
<TOTAL-COSTS>                                1,578,914
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           3,427,141
<INCOME-PRETAX>                              (292,640)
<INCOME-TAX>                                  (86,334)
<INCOME-CONTINUING>                          (206,306)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (206,306)
<EPS-PRIMARY>                                    (.04)
<EPS-DILUTED>                                    (.04)
        

</TABLE>
AHT 2015 Q1 10-Q - EX 10.4.1


 



EXHIBIT 10.4.1




May 8, 2015    
Ashford TRS Corporation
14185 Dallas Parkway, Suite 1100
Dallas, TX  75254


Ashford TRS VI Corporation
14185 Dallas Parkway, Suite 1100
Dallas, TX  75254
Ladies and Gentlemen:
Reference is made to that certain Purchase and Sale Agreement (the “Agreement”), dated as of February 18, 2015, by and between Ashford TRS Corporation, Ashford TRS VI Corporation and Ashford Select TRS Corporation.  Capitalized terms not otherwise defined in this letter have the meanings assigned in the Agreement.
The undersigned hereby notify you, pursuant to Section 2.3 of the Agreement, that the Agreement is terminated and of no further force and effect. 


Very truly yours,
ASHFORD SELECT TRS CORPORATION
By: /s/ DERIC EUBANKS    
Name:  Deric Eubanks
Title:    President
#### Andrew Wilson, Appellant, *v.*Joseph Vallin, Respondent.

Appeal from a judgment of the Municipal Court of the city of New York, borough of Manhattan.

C. E. Thornall, for appellant.

No appearance for respondent.

*Per Curiam.*

As the action was for conversion, the judgment, if in plaintiff’s favor, should have been for the damages and such disbursements and fees as the statute allows, and such costs as the trial justice in his discretion deemed proper, within the statutory limit. Consol. Act, § 1420.

Judgment reversed and a new trial ordered, with costs to abide the event.

Present: Truax, P. J., Scott and Dugro, JJ.

Judgment reversed and new trial ordered, with costs to appellant to abide event.
# C_2017090EN.01000801.xml

| 23.3.2017 | EN | Official Journal of the European Union | C 90/8 |
| --- | --- | --- | --- |

23.3.2017

EN

Official Journal of the European Union

C 90/8

---

JUDGMENT OF THE COURT

of 26 July 2016

in Case E-28/15

Yankuba Jabbi v The Norwegian Government, represented by the Immigration Appeals Board

(Directive 2004/38/EC — Right of residence — Derived rights for third country nationals)

(2017/C 90/09)

In Case E-28/15, Yankuba Jabbi v The Norwegian Government, represented by the Immigration Appeals Board – REQUEST to the Court under Article 34 of the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice by Oslo District Court (Oslo tingrett) concerning the interpretation of Article 7(1)(b) in conjunction with Article 7(2) of Directive 2004/38/EC on the right of citizens of the Union and their family members to move and reside freely within the territory of the Member States, the Court, composed of Carl Baudenbacher, President, Per Christiansen and Páll Hreinsson (Judge-Rapporteur), Judges, gave judgment on 26 July 2016, the operative part of which is as follows:

Oslo tingrett

Where an EEA national, pursuant to Article 7(1)(b) and Article 7(2) of Directive 2004/38/EC, has created or strengthened a family life with a third country national during genuine residence in an EEA State other than that of which he is a national, the provisions of that directive will apply by analogy where that EEA national returns with the family member to his home State.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Neurological Disorders and Stroke Special Emphasis Panel. Joint T-32 Review.                    

*Date:*                         November 2, 2009.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Lombardy, 2019 Pennsylvania Avenue, NW., Washington, DC 20006.                    

*Contact Person:*                         Phillip F. Wiethorn, Scientific Review Administrator, DHHS/NIH/NINDS/DER/SRB, 6001 Executive Boulevard; MSC 9529, Neuroscience Center; Room 3203, Bethesda, MD 20892-9529. (301) 496-5388.                         *wiethorp@ninds.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated: October 1, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-24171 Filed 10-8-09; 8:45 am]

BILLING CODE 4140-01-P
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED MAY 5, 2020

NO. 03-20-00140-CV

Brandon D. Hicks, Appellant

v.

Latisha D. Hicks, Appellee

APPEAL FROM COUNTY COURT AT LAW NO. 4 OF WILLIAMSON COUNTY

BEFORE JUSTICES GOODWIN, KELLY, AND SMITH

DISMISSED FOR WANT OF JURISDICTION -- OPINION BY JUSTICE SMITH

Having reviewed the record, it appears that the Court lacks jurisdiction over the appeal. 

Therefore, the Court dismisses the appeal for want of jurisdiction. Because appellant is indigent 

and unable to pay costs, no adjudication of costs is made.
#### Thomas H. Welch, Respondent, *v.*Louis D. Livingston et al., Appellants.

(Supreme Court, Appellate Term,

November, 1900.)

Quantum meruit — Recovery on, where performance of specific contract has been prevented by the other party.

Where a specific contract for work, labor and services has been only partially performed because the other party prevented completion, the party aggrieved is not confined to an action for the breach but may sue on a *quantum meruit*for the work done.

Appeal from a judgment of the Municipal Court of -the city of New York, second district, borough of Manhattan.

Shafer & Levin, for appellants.

Stake & Eckerson, for respondent.

*117*Per Curiam.*

This action was brought to recover for work, labor and services rendered by plaintiff to the defendants, and on conflicting evidence the jury found for the plaintiff. Although it appears a specific contract had been entered into between the parties the plaintiff was not confined to an action for damages for the breach thereof. Where a contract has been partially performed, and the defendants prevent the completion thereof, the aggrieved party may sue on a *quantum meruit*for the work done. Farron v. Sherwood, *17*E. Y. 227. As the items allowed for the expenses in returning the machine to Baltimore have not been incurred and are not reasonably certain to be incurred, they should have been withdrawn from the consideration of the jury.

The judgment will, therefore, be reduced to $171.79, and as modified, affirmed, without costs to either party.

Present: Beekman, P. J., Giegebich and O’Gobman, JJ.

Judgment reduced to $171.79, and as modified, affirmed, without costs.
§ 268.502 Compliance with final Commission decisions. ( a ) Relief ordered in a final Commission decision, if accepted pursuant to § 268.405(c) as a final decision, or not acted upon the Board within the time periods of § 268.405(c), is mandatory and binding on the Board except as provided in this section. Failure to implement ordered relief shall be subject to judicial enforcement as specified in § 268.503(f).
( b ) Notwithstanding paragraph (a) of this section, when the Board requests reconsideration and the case involves removal, separation, or a suspension continuing beyond the date of the request for reconsideration, and when the decision orders retroactive restoration, the Board shall comply with the decision to the extent of the temporary or conditional restoration of the employee to duty status in the position specified by the Commission, pending the outcome of the Board's request for reconsideration. ( 1 ) Service under the temporary or conditional restoration provisions of this paragraph (b) shall be credited toward the completion of a probationary or trial period or the completion of the service requirement for career tenure, if the Commission upholds its decision after reconsideration.
( 2 ) When the Board requests reconsideration, it may delay the payment of any amounts ordered to be paid to the complainant until after the request for reconsideration is resolved. If the Board delays payment of any amount pending the outcome of the request to reconsider and the resolution of the request (including under § 268.405(d)) requires the Board to make the payment, then the Board shall pay interest from the date of the original appellate decision until payment is made.
( 3 ) The Board shall notify the Commission and the employee in writing at the same time it requests reconsideration that the relief it provides is temporary or conditional and, if applicable, that it will delay the payment of any amounts owed but will pay interest as specified in paragraph (b)(2) of this section. Failure of the Board to provide notification will result in the dismissal of the Board's request.
( c ) When no request for reconsideration or final decision under § 268.405(d) is filed or when a request for reconsideration is denied, the Board shall provide the relief ordered and there is no further right to delay implementation of the ordered relief. The relief shall be provided in full not later than 120 days after receipt of the final decision unless otherwise ordered in the decision.
[68 FR 18085, Apr. 15, 2003, as amended at 84 FR 27034, June 11, 2019]
**Exhibit 32.1****Certification**          Pursuant to 18 U.S.C. Section 1350, the undersigned officer of Elcom International, Inc., aDelaware corporation (the “Company”), does hereby certify that the Company’s Annual Report on Form10-KSB for the year ended December 31, 2005 (the “Form 10-KSB”), fully complies with therequirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, asamended, and that the information contained in the Form 10-KSB fairly presents, in all materialrespects, the financial condition and results of operations of the Company as of, and for, theperiods presented in the Form 10-KSB.        Dated: March 23, 2006 /s/ John E. Halnen   John E. Halnen   President and Chief Executive Officer